United States Wound Biologics Market Insights 2023-2028: with Avita Medical, Organogenesis, Smith+Nephew, Vericel, and Orthofix Dominating [Yahoo! Finance]
Avita Medical, Inc. (RCEL)
Company Research
Source: Yahoo! Finance
US wound biologics market was valued at $630.00 million in 2022 and is expected to reach $1,214.92 million with a CAGR of 11.57% during the forecast period. This report offers market size & forecast data for the wound biologics market in the US. The revenue generated from product offerings is included in the report. This report provides a comprehensive and current market scenario of the US wound biologics market, including the US wound biologics market size, anticipated market forecast, relevant market segmentations, and industry trends. The market is witnessing growth driven by the increasing incidence of acute and chronic wounds, primarily attributed to factors like diabetes, surgical procedures, burns, and traumatic injuries. Additionally, the widespread adoption of advanced wound biologic products contributes to this expansion. In 2022, the product segment dominated by Biological Skin Substitutes held a substantial market share of 61.45%. This category is projected to maint
Show less
Read more
Impact Snapshot
Event Time:
RCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RCEL alerts
High impacting Avita Medical, Inc. news events
Weekly update
A roundup of the hottest topics
RCEL
News
- Avita Medical (NASDAQ:RCEL) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.MarketBeat
- AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- AVITA Medical to Present at the Piper Sandler 37?? Annual Healthcare ConferenceGlobeNewswire
- Avita Medical (NASDAQ:RCEL) was upgraded by analysts at BTIG Research from a "sell" rating to a "neutral" rating.MarketBeat
- AVITA Medical to Host Investor Webinar Briefing [Yahoo! Finance]Yahoo! Finance
RCEL
Earnings
- 11/6/25 - Miss
RCEL
Sec Filings
- 11/6/25 - Form 10-Q
- 11/6/25 - Form 8-K
- 10/17/25 - Form SCHEDULE
- RCEL's page on the SEC website